Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06488417 · ClinicalTrials.gov registry record · NA
Frankincense Supplements and Inflammation
A NA study, sponsored by dōTERRA International.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT06488417: Completed NA study, sponsored by dōTERRA International.
NCT06488417 is a NA study that has completed, run by dōTERRA International. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06488417, a NA study, has completed, sponsored by dōTERRA International.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn whether frankincense essential oil-based supplements can affect gene expression and serum protein markers in healthy volunteers. The main questions it aims to answer are: 1. Do frankincense essential oil supplements affect gene expression and protein markers as measured in blood? 2. How does daily ingestion of frankincense supplements affect anthropometric measurements, including body mass index, waist circumference, blood pressure, and heart rate? 3. How does daily ingestion of frankincense essential oil supplements affect subjective quality of life and health parameters? 4. Is ingesting frankincense essential oil supplements daily safe, as measured by laboratory tests and adverse events? Researchers will compare two types of frankincense essential oil supplements. One type contains frankincense essential oil and boswellic acid as its active ingredients. The other type contains only frankincense essential oil as its active ingredient. Participants will: * Be assigned one of the two types of frankincense essential oil supplement * Take two capsules of their assigned supplement every day for about 30 days * Attend two study visits in which they provide blood and urine samples, complete subjective health and quality of life assessments, and undergo anthropometric measurements * Complete weekly subjective health assessments from home
Interventions
- DIETARY_SUPPLEMENT Frankincense essential oil + boswellic acid supplement
- DIETARY_SUPPLEMENT Frankincense essential oil supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-06-17 |
| Est. Completion | 2024-08-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06488417
The ClinicalTrials.gov registry entry for NCT06488417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is dōTERRA International, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Frankincense essential oil + boswellic acid supplement is the first listed.
NCT06488417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06488417 about?
NCT06488417 is a clinical study titled "Frankincense Supplements and Inflammation". The goal of this clinical trial is to learn whether frankincense essential oil-based supplements can affect gene expression and serum protein markers in healthy volunteers. The main questions it aims to answer are: 1. Do frankincense essential oil supplements affect gene expression and protein mark...
What is the current status of trial NCT06488417?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2024-06-17. Estimated completion is 2024-08-21.
What interventions are being tested in trial NCT06488417?
The interventions under investigation include: Frankincense essential oil + boswellic acid supplement (DIETARY_SUPPLEMENT), Frankincense essential oil supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06488417?
This trial is sponsored by dōTERRA International, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.